Clinical trial
Biomarker Assessment of Glutamatergic Target Engagement
NCT02134951 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Assessment of Glutamatergic Target Engagement
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- November 30, 2015
- Enrollment
- 65 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
healthy controls